Valuation: Bausch + Lomb Corporation

Market Cap 6.23B 5.56B 5.13B 4.66B 8.74B 590B 8.87B 61.76B 24.33B 309B 23.37B 22.87B 979B P/E 2026 *
-286x
P/E 2027 * 45.1x
Enterprise Value 10.67B 9.52B 8.79B 7.98B 14.98B 1,011B 15.21B 106B 41.7B 530B 40.05B 39.2B 1,678B EV / Sales 2026 *
1.94x
EV / Sales 2027 * 1.79x
Free-Float
12.71%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Bausch + Lomb Corporation

1 day+1.46%
1 week+4.62%
Current month+2.53%
1 month+0.64%
3 months+9.28%
6 months+8.60%
Current year+2.05%
1 week 16.3
Extreme 16.3
17.45
1 month 15.47
Extreme 15.47
17.5
Current year 14.65
Extreme 14.65
18.92
1 year 14.44
Extreme 14.44
18.92
3 years 10.45
Extreme 10.45
21.69
5 years 10.45
Extreme 10.45
21.95
10 years 10.45
Extreme 10.45
21.95
Manager TitleAgeSince
Chief Executive Officer 64 2026-10-11
Director of Finance/CFO 53 2021-12-31
Compliance Officer - 2023-07-31
Director TitleAgeSince
Director/Board Member 62 2021-12-31
Director/Board Member 69 2022-04-30
Director/Board Member 78 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/12/26 Free

Director

11,776 0.0033%
8/12/26 Option

Director

11,776 0.0033%
8/12/26 Free

Director

11,776 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+4.62%+10.95%+3.08% 6.23B
+1.99%-2.07%-19.88%+5.92% 177B
+3.83%+1.19%+0.72%+32.86% 118B
+3.19%+4.72%-20.93%+15.58% 118B
+1.41%+16.35%-42.44%+8.55% 91.21B
-0.57%-0.86%+2.32%+79.33% 64.59B
-1.06%+1.75%+13.50%+80.00% 56.13B
+3.13%+3.44%+6.54%-22.51% 54.59B
+2.40%+3.58%-10.57%+32.73% 43.6B
-0.73%+5.04%-5.64%-11.32% 33.95B
Average +1.50%+4.26%-6.54%+22.42% 76.37B
Weighted average by Cap. +1.93%+3.56%-11.91%+22.26%

Financials

2026 *2027 *
Net sales 5.49B 4.9B 4.52B 4.11B 7.71B 520B 7.83B 54.49B 21.46B 273B 20.62B 20.18B 864B 5.82B 5.19B 4.79B 4.35B 8.17B 551B 8.29B 57.73B 22.74B 289B 21.84B 21.38B 915B
Net income -45.87M -40.95M -37.77M -34.32M -64.38M -4.35B -65.37M -455M -179M -2.28B -172M -168M -7.21B 132M 118M 109M 98.8M 185M 12.51B 188M 1.31B 516M 6.55B 496M 485M 20.76B
Net Debt 4.45B 3.97B 3.66B 3.33B 6.24B 421B 6.34B 44.1B 17.37B 221B 16.69B 16.33B 699B 4.17B 3.72B 3.43B 3.12B 5.85B 395B 5.94B 41.35B 16.29B 207B 15.65B 15.31B 655B
Projected Income Statement - Annual - Bausch + Lomb Corporation
Logo Bausch + Lomb Corporation
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Employees
13,000
Date Price Change Volume
26-10-22 US$17.43 +1.46% 426,368
26-10-21 US$17.18 +1.48% 450,784
26-10-20 US$16.93 +1.93% 502,440
26-10-19 US$16.61 +0.73% 357,031
26-10-16 US$16.49 -1.02% 419,847
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Bausch + Lomb Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17.43USD
Average target price
19.39USD
Spread / Average Target
+11.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bausch + Lomb Corporation
  1. Stock Market
  2. Stocks
  3. BLCO Stock